Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
BANF1 pseudogene 2 (BANF1P2), also known as bA122K13.8, is a processed pseudogene related to the BANF1 gene. Pseudogenes like BANF1P2 are typically nonfunctional copies of ancestral genes that have accumulated disabling mutations and are not transcribed or translated into functional proteins. Although some pseudogenes may have regulatory RNA capabilities, there is no evidence suggesting that BANF1P2 plays any functional, biological, or pathological role. It is not considered a therapeutic target and has no known involvement in disease or drug interactions[1][3].
Not applicable; no drugs target this pseudogene
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on BANF1 pseudogene 2 (BANF1P2).